Anne F Rositch1, Lu Mao, Michael G Hudgens, Stephen Moses, Kawango Agot, Danielle M Backes, Edith Nyagaya, Peter J F Snijders, Chris J L M Meijer, Robert C Bailey, Jennifer S Smith. 1. aDepartment of Epidemiology, John Hopkins Bloomberg School of Public Health bDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland cDepartment of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA dDepartments of Community Health Sciences, Medicine and Medical Microbiology, University of Manitoba, Winnipeg, Canada eImpact Research and Development Organization, Kisumu, Kenya fDepartment of Epidemiology, Brown University, Providence, Rhode Island, USA gUniversities of Nairobi, Illinois and Manitoba (UNIM), Kisumu, Kenya hDepartment of Pathology, VU University Medical Center, Amsterdam, the Netherlands iDivision of Epidemiology, University of Illinois at Chicago, Illinois jDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA.
Abstract
OBJECTIVES: There are very few data from men on the risk of HIV acquisition associated with penile human papillomavirus (HPV) infection and no data on the potential modifying effect of male circumcision. Therefore, this study evaluated whether HPV is independently associated with risk of HIV. DESIGN: A cohort study of HPV natural history nested within a randomized control trial of male circumcision to reduce HIV incidence in Kisumu, Kenya. METHODS: Prospective data from 2519 men were analyzed using 6-month discrete-time Cox models to determine if HIV acquisition was higher among circumcised or uncircumcised men with HPV compared to HPV-uninfected men. RESULTS:Risk of HIV acquisition was nonsignificantly increased among men with any HPV [adjusted hazard ratio (aHR) 1.72; 95% confidence interval (CI) 0.94-3.15] and high-risk HPV (aHR 1.92; 95% CI 0.96-3.87) compared to HPV-uninfected men, and estimates did not differ by circumcision status. Risk of HIV increased 27% with each additional HPV genotype infection (aHR 1.27; 95% CI 1.09-1.48). Men with persistent (aHR 3.27; 95% CI 1.59-6.72) or recently cleared (aHR 3.05; 95% CI 1.34-6.97) HPV had a higher risk of HIV acquisition than HPV-uninfected men. CONCLUSIONS: Consistent with the findings in women, HPV infection, clearance, and persistence were associated with an increased risk of HIV acquisition in men. Given the high prevalence of HPV in populations at risk of HIV, consideration of HPV in future HIV-prevention studies and investigation into mechanisms through which HPV might facilitate HIV acquisition are needed.
RCT Entities:
OBJECTIVES: There are very few data from men on the risk of HIV acquisition associated with penile human papillomavirus (HPV) infection and no data on the potential modifying effect of male circumcision. Therefore, this study evaluated whether HPV is independently associated with risk of HIV. DESIGN: A cohort study of HPV natural history nested within a randomized control trial of male circumcision to reduce HIV incidence in Kisumu, Kenya. METHODS: Prospective data from 2519 men were analyzed using 6-month discrete-time Cox models to determine if HIV acquisition was higher among circumcised or uncircumcised men with HPV compared to HPV-uninfectedmen. RESULTS: Risk of HIV acquisition was nonsignificantly increased among men with any HPV [adjusted hazard ratio (aHR) 1.72; 95% confidence interval (CI) 0.94-3.15] and high-risk HPV (aHR 1.92; 95% CI 0.96-3.87) compared to HPV-uninfectedmen, and estimates did not differ by circumcision status. Risk of HIV increased 27% with each additional HPV genotype infection (aHR 1.27; 95% CI 1.09-1.48). Men with persistent (aHR 3.27; 95% CI 1.59-6.72) or recently cleared (aHR 3.05; 95% CI 1.34-6.97) HPV had a higher risk of HIV acquisition than HPV-uninfectedmen. CONCLUSIONS: Consistent with the findings in women, HPV infection, clearance, and persistence were associated with an increased risk of HIV acquisition in men. Given the high prevalence of HPV in populations at risk of HIV, consideration of HPV in future HIV-prevention studies and investigation into mechanisms through which HPV might facilitate HIV acquisition are needed.
Authors: P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948
Authors: J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz Journal: J Pathol Date: 1999-09 Impact factor: 7.996
Authors: Adriaan J C van den Brule; René Pol; Nathalie Fransen-Daalmeijer; Leo M Schouls; Chris J L M Meijer; Peter J F Snijders Journal: J Clin Microbiol Date: 2002-03 Impact factor: 5.948
Authors: Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Jennifer S Smith; Stephen Moses; Michael G Hudgens; Kawango Agot; Silvia Franceschi; Ian W Maclean; J O Ndinya-Achola; Corette B Parker; Norma Pugh; Chris J L M Meijer; Peter J F Snijders; Robert C Bailey Journal: Sex Transm Dis Date: 2007-11 Impact factor: 2.830
Authors: Staci L Sudenga; B Nelson Torres; Matthys H Botha; Michele Zeier; Martha E Abrahamsen; Richard H Glashoff; Susan Engelbrecht; Maarten F Schim Van der Loeff; Louvina E Van der Laan; Siegfried Kipping; Douglas Taylor; Anna R Giuliano Journal: J Infect Date: 2015-10-19 Impact factor: 6.072
Authors: Ross D Cranston; Alex Carballo-Diéguez; Holly Gundacker; Barbra A Richardson; Rebecca Giguere; Curtis Dolezal; Aaron Siegel; Ratiya P KunjaraNaAyudhya; Kailazarid Gomez; Jeanna M Piper; Javier R Lama; Ian McGowan Journal: Int J STD AIDS Date: 2018-10-18 Impact factor: 1.359
Authors: Jeffrey Pudney; Zoon Wangu; Lori Panther; Dana Fugelso; Jai G Marathe; Manish Sagar; Joseph A Politch; Deborah J Anderson Journal: J Infect Dis Date: 2019-01-07 Impact factor: 7.759
Authors: Katharine J Looker; Jocelyn A R Elmes; Sami L Gottlieb; Joshua T Schiffer; Peter Vickerman; Katherine M E Turner; Marie-Claude Boily Journal: Lancet Infect Dis Date: 2017-08-23 Impact factor: 71.421
Authors: Staci L Sudenga; Sarah C Lotspeich; Alan G Nyitray; Bradley Sirak; Bryan E Shepherd; Jane Messina; Karen A Sereday; Roberto Carvalho Silva; Martha Abrahamsen; Maria Luiza Baggio; Manuel Quiterio; Eduardo Lazcano-Ponce; Luisa Villa; Anna R Giuliano Journal: Sex Transm Dis Date: 2022-01-01 Impact factor: 3.868
Authors: Etienne E Müller; Kevin Rebe; Tobias F Chirwa; Helen Struthers; James McIntyre; David A Lewis Journal: BMC Infect Dis Date: 2016-08-22 Impact factor: 3.090